INTRODUCTIONTumors in the sinonasal cavities represent 5% of all head and neck cancers with an incidence of approximately 0.5 of 100 000 inhabitants. Squamous cell carcinoma (SCC) and intestinal‐type adenocarcinoma (ITAC) represent approximately 70%‐80% of sinonasal cancer, the remainder include a miscellany of neuroendocrine carcinomas, neuroectodermal neoplasms, salivary gland tumors, and undifferentiated carcinomas. Sinonasal SCC and ITAC have been etiologically related to occupational exposures, including wood and leather dust, nickel, and chromium. There are also indications that human papillomavirus (HPV) and Epstein‐Barr virus play a role in the development of a subset of sinonasal cancer. Diagnosis of these tumors is often late due to unspecific symptoms similar to inflammatory processes.Despite improvements in the field of surgery and radiotherapy, the prognosis is still poor with a 5‐year overall survival of 30%‐50%. Typically, all sinonasal tumors frequently develop local recurrences (50%‐80%), the main cause of death. Lymph node or distant metastasis occur in 10%‐20% of cases. For locally advanced sinonasal tumors, treatment usually is surgery combined with radiotherapy, and, in some cases, a multimodal approach, including chemotherapy. However, there is a clear need for new therapeutic options.Molecular genetic studies may guide the application of modern anticancer drugs that target specific signaling pathways.
Head & Neck: Journal for the Sciences & Specialties of the Head and Neck – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera